TIMIStudyGroup's profile picture. Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.

TIMI Study Group

@TIMIStudyGroup

Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.

Pinned

TIMI is proud to celebrate our 40th anniversary! Since 1984, we've been dedicated to advancing the knowledge and care of patients suffering from cardiovascular disease and its risk factors. View the 40th anniversary edition of the TIMI book, now online. timi.org/40th-anniversa…


Dive into the latest in 🫀 cardiovascular research with 'From the Chairman's Corner', where Dr. Marc Sabatine discusses groundbreaking insights from the CORE and CORE2 TIMI trials and how #olezarsen is reshaping treatment for severe hypertriglyceridemia. timi.org/from-the-chair…

TIMIStudyGroup's tweet image. Dive into the latest in 🫀 cardiovascular research with 'From the Chairman's Corner', where Dr. Marc Sabatine discusses groundbreaking insights from the CORE and CORE2 TIMI trials and how #olezarsen is reshaping treatment for severe hypertriglyceridemia. timi.org/from-the-chair…

TIMI investigator @DrM_ODonoghue speaks with Dr. Ann Marie Navar about the results of #VESALIUS and #CORALreef Lipids that examine new data for both injectable and oral PCSK9i. @Medscape medscape.com/viewarticle/ti…


TIMI Study Group reposted

A new study shows that a triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients. Read more from @marstonMD and the @TIMIStudyGroup: massgeneralbrigham.org/en/about/newsr… nejm.org/doi/full/10.10… @NEJM

MGBResearchNews's tweet image. A new study shows that a triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients. 

Read more from @marstonMD and the @TIMIStudyGroup: massgeneralbrigham.org/en/about/newsr… nejm.org/doi/full/10.10… @NEJM

TIMI Study Group reposted

Is CELEBRATE a game changer? See the commentary by @TIMIStudyGroup Prof. David Morrow and myself in @ESC_Journals ACVC Evaluating subcutaneous glycoprotein IIbIlla inhibition at first medical contact in STEMI - reviving an old concept with a new agent? doi.org/10.1093/ehjacc…

krychtiukmd's tweet image. Is CELEBRATE a game changer? See the commentary by @TIMIStudyGroup Prof. David Morrow and myself in @ESC_Journals ACVC

Evaluating subcutaneous glycoprotein IIbIlla inhibition at first medical contact in STEMI - reviving an old concept with a new agent?

doi.org/10.1093/ehjacc…
krychtiukmd's tweet image. Is CELEBRATE a game changer? See the commentary by @TIMIStudyGroup Prof. David Morrow and myself in @ESC_Journals ACVC

Evaluating subcutaneous glycoprotein IIbIlla inhibition at first medical contact in STEMI - reviving an old concept with a new agent?

doi.org/10.1093/ehjacc…

TIMI Study Group reposted

#ICYMI #OriginalResearch, DAPA ACT HF-TIMI 68 trial: in-hospital initiation of dapagliflozin did not significantly⬇️risk of CV death or worsening HF compared w/ place... ahajrnls.org/3LMUam7 @SubodhVermaMD @akshaydesaimd @UoGHeartFailure @modeldoc @TIMIStudyGroup @ddbergMD

CircAHA's tweet image. #ICYMI #OriginalResearch, DAPA ACT HF-TIMI 68 trial: in-hospital initiation of dapagliflozin did not significantly⬇️risk of CV death or worsening HF compared w/ place... ahajrnls.org/3LMUam7  @SubodhVermaMD @akshaydesaimd @UoGHeartFailure @modeldoc @TIMIStudyGroup  @ddbergMD

Coverage in @COR2EDMedEd of TIMI lipid management trials VESALIUS and CORE/CORE2 presented at #AHA25 @rgiugliano cor2ed.com/coronary-conne…


In this first look of the AHA CS Registry, inopressors (specifically norepi) most commonly used vasoactive for CS; however, clear differences by etiology (AMI-CS vs AoC HF-CS), severity, concomitant MCS. Full manuscript now at #JAHA ahajournals.org/doi/10.1161/JA… @sidpatelMD #AHA25

TIMIStudyGroup's tweet image. In this first look of the AHA CS Registry, inopressors (specifically norepi) most commonly used vasoactive for CS; however, clear differences by etiology (AMI-CS vs AoC HF-CS), severity, concomitant MCS. Full manuscript now at #JAHA ahajournals.org/doi/10.1161/JA… @sidpatelMD #AHA25
TIMIStudyGroup's tweet image. In this first look of the AHA CS Registry, inopressors (specifically norepi) most commonly used vasoactive for CS; however, clear differences by etiology (AMI-CS vs AoC HF-CS), severity, concomitant MCS. Full manuscript now at #JAHA ahajournals.org/doi/10.1161/JA… @sidpatelMD #AHA25
TIMIStudyGroup's tweet image. In this first look of the AHA CS Registry, inopressors (specifically norepi) most commonly used vasoactive for CS; however, clear differences by etiology (AMI-CS vs AoC HF-CS), severity, concomitant MCS. Full manuscript now at #JAHA ahajournals.org/doi/10.1161/JA… @sidpatelMD #AHA25
TIMIStudyGroup's tweet image. In this first look of the AHA CS Registry, inopressors (specifically norepi) most commonly used vasoactive for CS; however, clear differences by etiology (AMI-CS vs AoC HF-CS), severity, concomitant MCS. Full manuscript now at #JAHA ahajournals.org/doi/10.1161/JA… @sidpatelMD #AHA25

Latest #CCCTNetwork research shows overall 5% MCS device complication rate (range 2.8–10.9%). IABP (axillary ≫ femoral) and Impella CP > 5.0/5.5. Vascular (63%) ≫ Thrombotic (13%). Complications → ↑ ICU LOS & mortality. #CardioICU #Cardiogenic Shock #MCS #WaronShock #AHA25


TIMI investigators @DrM_ODonoghue and @marstonMD share their insights on the latest phase 3 data for the oral PCSK9 inhibitor, enlicitide, in @JAMANetwork jamanetwork.com/journals/jama/…


New data from the OCEAN(a) DOSE - TIMI 67 trial indicates that siRNA #olpasiran reduces Lp(a) irrespective of apo(a) isoform size and affects both isoforms equally. @DrM_ODonoghue #AHA25

TIMIStudyGroup's tweet image. New data from the OCEAN(a) DOSE - TIMI 67 trial indicates that siRNA #olpasiran reduces Lp(a) irrespective of apo(a) isoform size and affects both isoforms equally. @DrM_ODonoghue  #AHA25

Novel biomarker for neuroprognostication in cardiac arrest (kynureninase) emerges from MGB CICU research @CCCTNetwork @ebohula #AHA25


Tomorrow at 1:30pm, Dr. @marstonMD will dive deeper into the CORE-TIMI 72a and CORE2-TIMI 72b results when he joins Meet the Trialists at CardioTalk 1 @rgiugliano @BrianBergmark #AHA25


Loading...

Something went wrong.


Something went wrong.